abstract: The multinucleate syncytiotrophoblast of the human placenta is formed by fusion of the underlying cytotrophoblast progenitor cells. The large surface area of the syncytiotrophoblast is necessary for transport functions while it also serves as the site of synthesis of hormones and steroids. Studies of syncytiotrophoblast transcription are puzzling, demonstrating that many of the nuclei in the multinucleated syncytium are transcriptionally inactive. To further elucidate RNA activity in the syncytiotrophoblast, we investigated expression of snRNAs involved in RNA splicing. Using RNA in situ hybridization, we observed that snRNAs were markedly reduced in the syncytium throughout the course of pregnancy. Recapitulating these results in primary trophoblasts and in trophoblast cell lines in vitro, we found, using qRT-PCR and RNA in situ hybridization, that snRNA expression is reduced in trophoblasts cultured under fusion conditions. Our finding that snRNA is markedly reduced in the syncytiotrophoblast suggests that the placenta has evolved a balance between the large surface area essential for its transport function and the need to regulate protein production in the multinucleated syncytium.
Introduction
In a process that continues throughout pregnancy, the syncytiotrophoblast of the growing placenta is formed by fusion of the underlying progenitor cells, the cytotrophoblasts. Development of the multinucleate syncytiotrophoblast creates a barrier between maternal blood filling the intervillous space between the chorionic villi and that of the fetal vessels within. This terminally differentiated and continuous epithelial syncytium provides a large surface area of almost 12 m 2 at term for an efficient discharge of the respiratory and transport functions of the placenta (Boyd, 1970; Ellery et al., 2009) . Among its many tasks the syncytiotrophoblast functions as the site of protein synthesis. Yet, studies of syncytiotrophoblast transcription are intriguing, demonstrating that most of the syncytiotrophoblast nuclei, estimated at term to number 58 × 10 9 (Simpson et al., 1992; Mayhew and Simpson, 1994) are not only non-mitotic but also mostly transcriptionally inactive. Several lines of evidence suggest that transcription is down-regulated in the syncytium of the human placenta with perhaps only a subset of nuclei active in transcription. These studies include lack of nuclear staining for both an antibody for the active form of RNA polymerase II and for the dimethylated histone H3, generally associated with transcriptionally active euchromatic regions, as well as the failure to incorporate H 3 -uridine in the syncytiotrophoblast nuclei (Huppertz et al., 1998; Ellery et al., 2009; Huppertz, 2010) . Chromatin condensation of syncytiotrophoblast nuclei is described as heterogeneous and may reflect the fact that the nuclei have fused at different times during pregnancy (Ellery et al., 2009; Huppertz, 2010) . RNA splicing and transcription are intimately connected, with most intronic splicing occurring co-transcriptionally (Carrillo Oesterreich et al., 2011) . We investigated small nuclear RNA (snRNA) expression in placenta as an indicator of active splicing of pre-mRNA to form mRNA. Splicing is conducted through the spliceosome complex composed of snRNAs, which following transcription in the nucleus combine in the cytoplasm with either the Sm (antigens targeted by antibodies from a systemic lupus erythematosus patient named Smith) proteins or the Lsm (Like Sm) proteins (in the case of U6) to form small nuclear ribonucleoprotein (snRNP) complexes. The complexes then reenter the nucleus to engage in splicing of the pre-mRNA. The U6 snRNA is highly conserved in terms of size, structure and sequence in evolution from yeast to mammals (Brow and Guthrie, 1988) . The U2/U6 snRNP complex initiates the first catalytic step in splicing (Sun and Manley, 1995) . Using an RNA in situ hybridization procedure adapted from miRNA techniques, we observed that snRNAs are mostly absent from the syncytiotrophoblast. This finding was also recapitulated in cell culture in in vitro fusion of primary trophoblasts and trophoblast cell lines and observed in both RNA in situ hybridization as well as quantitative real-time PCR. Term placenta produces 250 mg or more of progesterone per day and 1 g of human placental lactogen per day (Simpson and MacDonald, 1981) . Our finding that snRNA is down-regulated in the syncytiotrophoblast adds another dimension to the enigma of a transcriptionally down-regulated but translationally active syncytium. Since transport and protein production are two major physiological roles of the syncytiotrophoblast, a molecular process had to evolve to develop the large placental surface area while not overwhelming protein production. Our observation of down-regulation of splicing and hence transcription raises the possibility that this is a method that the placental syncytiotrophoblast employs to regulate levels of protein production during pregnancy while maintaining a very large surface area to fulfill the needs of the fetus through transport of nutrients, wastes and gases.
Materials and Methods

Placental tissue
For isolation of first-trimester trophoblasts we used (Institutional Review Board approved) de-identified, pooled and waste placenta materials from first-trimester elective terminations of pregnancy (8 -12 weeks gestation) with the explicit condition that DNA not be isolated from the samples. The archived paraffin placenta samples are de-identified. Ten placentas from normal pregnancies were examined: four from the first-trimester (gestational range 8 -12 weeks) and six from the third-trimester (38-41 weeks of gestation, four vaginal deliveries and two Cesarean deliveries). A minimum of five slides were examined from each block.
snRNA in situ hybridization
Using a technique modified for use from miRNA in situ hybridization, U6 and U2 snRNA were detected using a double DIG labeled antisense probe, (U6 5 ′ CACGAATTTGCGTGTCATCCTT, U2 5 ′ ATATATTGTCCTCGGATA GAGGG) and as negative control a scrambled (5 ′ GTGTAACACGTCTA TACGCCCA) LNA TM probe (Exiqon, Denmark) according to the manufacturer's instructions with minor modifications. Following dewaxing, slides were incubated with proteinase K (10 mg/ml, Sigma-Aldrich) for 20 min at 378C. After RNA in situ hybridization and washings, slides were treated with peroxidase and incubated overnight at 48C with Anti-Digoxigenin-POD (poly), FAB fragments, (Roche Diagnostics, Germany), 1:50 in a humidified chamber. The following morning the slides were washed (phosphatebuffered saline, PBS) and incubated at RT for 10 min in the dark with TSA TM Plus Cyanine 3 (Cy3) system (Tyramide Signal Amplification with Cyanine 3 fluorescence producing a red fluorescent signal, catalogue number NEL744001KT, PerkinElmer, Massachusetts). Slides were washed and mounted with DAPI mounting (UltraCruz TM Mounting Medium, sc-24941, Santa Cruz Biotechnology, CA).
Fluorescent microscopy was performed using an Olympus BX41, U-RFL-T microscope. Confocal microscopy was performed at the Bioimaging facility of Hebrew University. Imaging was performed using the FV-1000 confocal microscope (Olympus, Japan), equipped with an IX81 inverted microscope. A 60×/1.4 oil immersion objective was used.
snRNA in situ co-detection with E-cadherin E-cadherin co-detection with the snRNA was performed using a modified frozen section procedure. Briefly, slides were washed (in PBS) and fixed with 4% paraformaldehyde on ice for ten minutes. Slides were washed and treated with triton x-100, washed and de-acetylated. Probe incubation and detection were performed as for FFPE sections. After TSA-cy3 amplification the slides were blocked with CAS buffer (a universal blocking reagent, Zymed laboratories, CA) for 15 min and incubated for 3 h at room temperature with anti-human E-cadherin antibody, NorthernLights TM 493 conjugated goat polyclonal antibody, 1:20 (R&D systems, Minneapolis, MN). Slides were washed and mounted with DAPI mounting medium.
Tissue culture
Single-cell cytotrophoblast cultures were established from pooled firsttrimester human placentas (8-12 weeks of gestation). First-trimester placental cells from elective pregnancy terminations were studied in accordance with the protocol for the study of human subjects approved by our institutional board. Cytotrophoblasts were isolated and purified as described (Kliman et al., 1986) with some modifications of our laboratory (Shimonovitz et al., 1994; Hanna et al., 2006) . Placental tissue was placed in ice-cold saline and processed within the hour. Briefly, the placental tissue was rinsed with PBS and the soft villous material was cut away from connective tissue and bloody tissue fragments. The villous tissue was incubated for 30 min at 378C in Hank's balanced salt solution (HBSS) containing 0.125% trypsin type XII-S (Sigma, St. Louis, MO), 3 mM EDTA and 0.2 mg/ml deoxyribonuclease I (Sigma, St. Louis, MO, USA). The dissociated cells were isolated by centrifugation, resuspended in medium and layered over a discontinuous Percoll (Pharmacia, Sweden) gradient (15-70%) prepared in HBSS. The middle bands of the gradient (35-55%), containing the cytotrophoblasts were collected and washed several times with culture media (DMEM: F12(HAM), 1:1) and 15% heat-inactivated fetal calf serum (FCS). The remaining leukocytes were removed as previously described by our laboratory (Shimonovitz et al., 1994) . All tissue culture supplies were purchased from Biological Industries Inc. (Beit Haemek, Israel) unless otherwise specified. Using this method we isolate trophoblasts with cell purities of over 95% (Hanna et al., 2006) . Our methods for validating purity of the isolated trophoblasts have been described (Hanna et al., 2006) . All cell culture experiments were performed in a humidified incubator (Heraeus, Thermo Electron Corporation, Germany) at 378C, 5% CO 2 in air.
Then 2 × 10 5 isolated primary trophoblasts were plated on permanox Lab Tek chamber slides (Nalge Nunc International, IL); cells and were maintained up to Day 4 in culture in DMEM-F12 + 15% FCS. In addition, trophoblast identity was ascertained using a monoclonal mouse anti-human antibody to cytokeratin 7 (mouse anti-human Cytokeratin 7, mouse IgG1 clone OV-TL 12/30 Dako, Denmark) on the plated cells. JEG-3 cells (purchased from ATCC) were maintained in RPMI 1640 with 10% FCS. Cells were plated subconfluent for the fusion experiments at 5 × 10 4 cells per well.
BeWo cells (purchased from ATCC) were cultured in F-12 (Hams) with 10% FCS. Cells were plated subconfluent for the fusion experiments at 1 × 10 5 cells per well (Nunc, Naperville, IL, permanox four well, catalogue number 177445). Cell culture reagents were purchased from Biological Industries (Beit Haemek). For fusion experiments, 24 h after cell plating the media was changed and forskolin (prepared in DMSO) with final concentration 20 mM mg/ml (Sigma-Aldrich), was added, with only the DMSO carrier added to control wells.
For real-time PCR experiments, optimal cell seeding was found to be 2.5 × 10 5 cells/well for BeWo cells and 1.75 × 10 5 cells/well for JEG-3 cells, in a 12-well plate. All cell culture experiments were performed in duplicate wells for both forskolin treated and controls (DMSO only). Medium was removed for determination of bhCG concentration and RNA was isolated at time 0, 24, 48 and 72 h after the addition of forskolin. Cells were photographed at 72 h. The entire experiment was repeated three times. SD error bars are included. Fusion was evaluated with the formation of nuclear aggregates and the immunohistochemical observation of the disappearance of E-cadherin expression in fused cells. bhCG was examined by immunoassay (Roche) on the Cobas E601 machine.
Quantitative RT-PCR RNA was isolated from the BeWo and JEG-3 forskolin and control time course cell culture experiments (all performed in duplicate wells) using the miRNeasy mini kit according to the manufacturer's instructions (Quiagen, Germany). RNA concentration was determined using the NanoDrop 2000 (Thermo-Scientific, Wilmington, DE). RNA (20 ng) was reversed transcribed using the mirCURY LNA Universal RT microRNA/PCR kit (Exiqon, Denmark) according to the manufacturer's instructions with the PTC-200 machine (MJ Research). Real-time PCR was performed using SYBR Green detection with the Light Cycler (Roche-Applied Sciences, Germany) and U6 snRNA and 5S RNA primers (catalogue numbers 203907 and 203906, respectively, Exiqon, Denmark). Reactions were performed in duplicate with no-template control reactions. snRNA U6 expression was normalized to 5S. 
Reduced snRNA in placental syncytiotrophoblast
The real-time PCR was performed twice, in two independent experiments. Each one included cDNA synthesized from two sets of cell cultures, for all time points analyzed, including BeWo, JEG-3 cells with forskolin and control.
Results
snRNA expression is reduced in syncytiotrophoblast of normal placenta First-trimester, formalin-fixed paraffin-embedded (FFPE) placental sections (from four different placentas) were examined for snRNA expression (U2 and U6). In the chorionic villi, we observed snRNA expression in the nuclei of: stromal cells, cells of the fetal vasculature, cytotrophoblasts and in extravillous trophoblasts forming cell columns but not in the majority of the syncytiotrophoblast nuclei (Fig. 1A -E) . We observed the same pattern of expression using U2 and U6 snRNA probes in situ and representative sections are shown for both probes (Fig. 1) . Occasionally, we were able to observe several positive nuclei in the syncytium (Fig. 1B) . Using the RNA in situ technique, we are unable to discern whether these positive cells represented recently fused nuclei that continue to retain the snRNAs or if they represented a subset of syncytial nuclei where transcription persists post fusion. This latter possibility raises questions of how lateral control of transcriptional regulation of the nuclei within the syncytium occurs. In third-trimester placental sections (from six different placentas), similarly to first-trimester sections, the snRNAs were downregulated in the syncytiotrophoblast (Fig. 1E ) but were readily observed in the stromal cells of the chorionic villi and also in cytotrophoblasts. Furthermore, using confocal microscopy to view the villous structures more clearly in DIC, snRNA in situ hybridization was not observed in the syncytiotrophoblast of third-trimester placental sections ( Fig. 2A) but was readily observed in villous stromal cells. A scrambled probe was included in each experiment (Fig. 2B) as a negative control.
snRNA is down-regulated in fusion of trophoblasts in cell culture
The cytotrophoblast progenitor cells fuse throughout pregnancy to form the syncytium, hence we next performed cell fusion experiments in tissue culture. In an effort to recapitulate in vitro the observed down-regulation of snRNA expression in syncytiotrophoblast sections we characterized snRNA expression in trophoblast cell lines (choriocarcinoma and primary trophoblasts). JEG-3 cells do not fuse in vitro but BeWo cells will fuse upon treatment with forskolin (an activator of adenylate cyclase; Al-Nasiry et al., 2006; Fradet et al., 2012) . Nuclear aggregation and dissipation of E-cadherin are used as indicators of cell fusion (Coutifaris et al., 1991; Al-Nasiry et al., 2006) . In situ hybridization of JEG-3 cells with a U6 probe revealed expression of U6 snRNA in all nuclei examined with co-detection of the cell membrane using an E-cadherin antibody (Fig. 3A) . In situ hybridization revealed distribution of snRNA with nucleolar sparing (Fig. 3A) . Of particular interest is that the snRNA appears in a speckled pattern reminiscent of that previously described in the immunofluorescence of proteins of the snRNP complex (Fig. 3A ) (Spector and Lamond, 2011) . This speckled snRNA pattern of the interchromatin region of the nucleoplasm, the interchromatin granule clusters, are storage sites of splicing factors. The distribution of the snRNA in structures of mitotic nuclei was also observed (Fig. 3B) , with a striking appearance as the snRNA appears excluded from the chromatin. Furthermore, we observed snRNA in the focal plane of the cytoplasm, which is most likely indicative of the snRNA in the process of either exiting or entering the cytoplasm and forming the snRNP complex for transport to the nucleus (Fig. 3C) .
Using confocal microscopy of U6 snRNA in situ hybridization in firsttrimester placental sections, we observed a positive signal in the cytotrophoblasts in a punctate pattern with down-regulation of snRNA in the syncytiotrophoblast. However, the resolution is less clear than in the cell culture, most likely because of the thickness of the sections (Fig. 4) . Confocal microscopy of the boxed area in (A) (original magnification 600×) with cytotrophoblasts positive for snRNA expression (white arrow) and negative or dimly visible for snRNA in the syncytiotrophoblast (hollow arrow). Nuclei are stained blue with DAPI and snRNA appears red (cy3) and in the merged image the snRNA co-localizing with the DAPI stain appears pink.
Reduced snRNA in placental syncytiotrophoblast
Using the co-detection technique (snRNA and E-cadherin) for BeWo cells grown in cell culture, we observed, as in JEG-3 cells, snRNA expression in all nuclei (Fig. 5A) . However, under fusion conditions, snRNA nuclear staining was no longer uniform ( Fig. 5B) : some nuclei were brightly and others dimly stained. The fused cell nuclei appeared to aggregate, and, as expected, the E-cadherin staining pattern disappeared or became indistinct, cloudy and disorganized (Fig. 5B) , while the snRNA signal was dim or below our level of detection. Within the same microscopic field (Fig. 5B ) unfused cells were also observed and these have maintained snRNA and E-cadherin expression. Expanding these experiments to primary culture of cytotrophoblasts, which spontaneously fuse when cultured in vitro, we found that the snRNA was also dimly visible or below our level of detection in the fused cells (Fig. 5C ).
Real-time PCR detection of snRNA down-regulation
In an effort to quantify the down-regulation of snRNA in the cell culture experiments, BeWo and JEG-3 cells were grown under fusion and nonfusion conditions. bhCG levels in the conditioned media of both JEG-3 and BeWo cells cultured with forskolin rise precipitously over a 3-day period, with levels in the JEG-3 cells almost 4-fold higher than those observed in the BeWo cells ( Fig. 5D and E) . bhCG levels were similar at 48 h and 72 h in the forskolin-treated BeWo cells but continued to rise in the forskolin-treated JEG-3 cells ( Fig. 5D and E) . As reported by others, JEG-3 cells produce bhCG under forskolin conditions although they do not fuse. This has led researchers to conclude that not all morphological changes (fusion in the choriocarcinoma cells) go hand in hand with biochemical changes in protein expression, in this case bHCG (Al-Nasiry et al., 2006; Orendi et al., 2010) . Real-time PCR was performed to quantify U6 expression in cells grown under fusion conditions in culture. In JEG-3 cells treated with forskolin, U6 snRNA expression remained fairly steady over a 48-h period, whereas in BeWo cells cultured under fusion conditions, U6 snRNA decreased by 3-fold (Fig. 5F ). Thus, while continuing to produce bhCG, the BeWo cells down-regulated U6 expression.
Discussion
Using RNA in situ hybridization, we observed that snRNAs (U2 and U6) are markedly reduced in the syncytiotrophoblast of the human placenta. Recapitulating these results in primary trophoblasts and in trophoblast cell lines in vitro using qRT-PCR and RNA in situ hybridization, we found that snRNA expression is reduced in trophoblasts cultured under fusion conditions. We interpret these results as suggesting that, while the placenta has evolved a large surface area to provide nutrients, gas exchange, and waste removal and to act as a partial barrier to nurture and protect the developing fetus, a mechanism evolved to control protein production in the multinucleate syncytium. Our snRNA data, supported by previous reports of transcriptional down-regulation, suggest that one such mechanism of protein regulation is transcriptional down-regulation in the syncytium (Huppertz et al., 1998; Ellery et al., 2009; Huppertz, 2010) . The extent of the reported syncytial nuclei with transcriptional reduction is most likely a reflection of the techniques employed. When immunohistochemistry and immunofluorescence combined with the dissector were used, active pol II was observed in only 20 -40% of total nuclei (Fogarty et al., 2011) . Overall we observed a greater transcriptional reduction in syncytial nuclei than Fogerty et al. However, Fogerty et al. used immunohistochemistry and immunofluorescence (for protein detection), while we used RNA in situ hybridization (for detection of splicing snRNAs). It is very likely that the half-lives (protein or snRNA) may differ. Furthermore, down-regulation may be staggered, with splicing down-regulated before active transcription. Neither we nor the Fogarty group measured transcription directly as we both analyzed placental sections. In addition, we performed our experiments on individual sections that do not reflect the dramatic gestational increase in placental volume.
In some ways the difference between our findings reflects a difference in interpretation. Fogarty et al. interpreted the finding of transcription factors in nuclei as evidence for transcriptional activity in the syncytium and as a basis for explaining the fact that the syncytium is actively producing proteins. Conversely, we view the biologically unusual finding of lack of transcription in many syncytial nuclei as a clue to an idiosyncratic evolutionary balance between the need for large surface area versus down-regulated protein production. The biological mechanism for this down-regulation is an area ripe for further research, particularly surrounding the questions of lateral control and the positional effect of transcriptional activity in the multinucleate syncytium.
Observed transcriptional down-regulation in syncytiotrophoblasts of normal placentas opens an avenue of inquiry into the possibility of aberrant down-regulation in placental pathologies. Target pathologies might include complete hydatidiform mole placentas, where only the paternal genome is present, as well as placentas of gestational trophoblastic disease and pre-eclampsia. Cytotrophoblasts of trisomy 21 show defects in syncytial fusion (Pidoux et al., 2012) and maternal secondtrimester serum hCG levels in these pregnancies are 2-fold greater than in mothers carrying euploid fetuses. The association between hCG secretion and cell fusion in trisomy 21 trophoblasts is suggestive of defective hCG signaling and placental development in these placenta (Pidoux et al., 2007) . How these observations relate to the observed reduction in snRNA expression of syncytiotrophoblasts in normal placenta remains to be investigated.
In conclusion, by reducing transcription in the syncytiotrophoblast, the placenta has achieved a balance between the large surface area necessary to fulfill its transport function and the need to regulate protein production in the multinucleated syncytium.
